ASCAPE Open Call will provide a sum to healthcare institutes, companies or research teams with the aim of evaluating the efficacy and applicability of our solution and AI models achieving broader participation and involvement in the ASCAPE framework development. In parallel, through this Open Call, we aspire to expand its application to other types of cancers or medical conditions.
Evaluation of ASCAPE Open AI infrastructure in healthcare institutions
Objective: Evaluate the developed AI models and the whole ASCAPE solution in, external to the consortium, Healthcare Providers, SMEs in the field of Health & doctors in private practice.
Contribute new algorithms to improve or/and train ASCAPE Open AI infrastructure to detect new types of cancer or medical conditions
Objective: Seek for external AI /ML SMEs or research teams with expertise on cancer-related medical applications to provide the consortium with new algorithms AI/ML models to be incorporated in our solution enhancing its efficacy & expanding its application to other types of cancers or medical conditions.
Up to €250.000 for 3 to 5 third party beneficiaries with a 100% funding rate.
For sub-call 1: Hospitals, healthcare Institutes, SMEs in the field of healthcare & patient’s Quality of Life, tackling different kinds of cancers from EU and associated countries. Consortia are not excluded.
For sub-call 2: AI / ML SMEs, research organizations with expertise on cancer-related medical applications from EU and associated countries. Consortia are not excluded.
The launch day of the ASCAPE Open Call is September 14, 2021, and proposals from the third parties will be admitted by December 10.
Up to €250.000, access to an operational version of ASCAPE solution (sub-call1), access to ASCAPE framework (sub-call2), synthetic data samples, technical guidance, collaboration communication services.
The ASCAPE project consists of a consortium of 15 partners, from 10 countries involving big companies, SMEs, research centres and universities. ASCAPE partners bring state-of-the-art complementary skills ensuring the ability of the consortium to deliver innovative solutions.